Newly formed Radcliffe Department of Medicine launches

25 March 2013

The Radcliffe Department of Medicine (RDM) is today (25 March 2013) hosting its Inaugural Symposium. RDM, which is part of the University of Oxford’s Medical Sciences Division, brings together about 500 staff from several research areas.

The symposium showcased the breadth of research conducted within RDM and gave researchers from across the department the opportunity to hear about their colleagues work and share ideas. In an effort to increase internal collaborations, RDM has developed an innovative funding scheme in which researchers collaborating across the department will be eligible to apply for additional funding.

The Radcliffe Department of Medicine was formed in 2012 through an amalgamation of the Departmentof Cardiovascular Medicine, the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), the majority of research groups from the MRC Weatherall Institute of Molecular Medicine (WIMM), the Nuffield Department of Clinical Laboratory Sciences, the Oxford Acute Vascular Imaging Centre (AVIC) and the academic groups in Geratology and Stroke who were formerly members of the Nuffield Department of Medicine, Experimental Medicine Division. These latter groups, together with a new programme in Experimental Therapeutics and the new Centre for the Advancement of Sustainable Medical Innovation (CASMI), will now constitute the Investigative Medicine Division (IMD) of RDM.

Head of Department, Professor Hugh Watkins commented: “The motivation for forming the RDM was to bring groups together that could add value to one another and I think the breadth and quality of research presented today shows just how great the potential is."

Links:

Radcliffe Department of Medicine

Medical Sciences Division

Review highlights risk factors associated with violence in schizophrenia

20 January 2022

Researchers at Oxford University’s Department of Psychiatry have found that people with schizophrenia and related disorders are at higher-than-average risk of perpetrating violence, but that the overall risk remains low (less than 1 in 20 in women, and less than 1 in 4 for men over a 35-year period for violent arrests and crimes).

An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections

20 January 2022

First comprehensive analysis of global impact of antimicrobial resistance (AMR) estimates resistance itself caused 1.27 million deaths in 2019 - more deaths than HIV/AIDS or malaria - and that antimicrobial-resistant infections played a role in 4.95 million deaths.

Attention and memory deficits persist for months after recovery from mild Covid

19 January 2022

Researchers from Oxford’s Department of Experimental Psychology and Nuffield Department of Clinical Neurosciences have shown that people who have had Covid but don’t complain of long Covid symptoms in daily life nevertheless can show degraded attention and memory for up to 6-9 months.

Plaster cast or metal pins to treat a broken wrist? The results are in.

19 January 2022

An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.

New book expands the horizons of brain research

18 January 2022

A pioneering book from Professor Zoltán Molnár and Yale Professors Tamas Horvath and Joy Hirsch to be released on 1 February 2022 addresses the fundamental relationship between the body, brain and behaviour.

New research sheds light on how ultrasound could be used to treat psychiatric disorders

14 January 2022

A new study in macaque monkeys has shed light on which parts of the brain support credit assignment processes (how the brain links outcomes with its decisions) and, for the first time, how low-intensity transcranial ultrasound stimulation (TUS) can modulate both brain activity and behaviours related to these decision-making and learning processes.